Form 4: Voyager Therapeutics Chief Scientific Officer Sells Shares
SEC Form 4 Filing
Todd Alfred Carter, Chief Scientific Officer of Voyager Therapeutics, sold 1,191 shares of common stock at an average price of $5.13 on January 14, 2025.
Summary
- On January 14, 2025, Todd Alfred Carter, the Chief Scientific Officer of Voyager Therapeutics, sold 1,191 shares of the company's common stock.
- The shares were sold at a weighted average price of $5.13.
- The sales occurred in multiple transactions with prices ranging from $5.05 to $5.30.
- Following the transaction, Carter directly owns 86,436 shares of Voyager Therapeutics.
Sentiment
Score: 5
Explanation: This is a neutral event. An executive selling shares doesn't necessarily indicate a negative outlook, as it could be for personal financial reasons.
Industry Context
This is a routine disclosure of an insider stock sale. It's common for executives to periodically sell shares for personal financial management.
Stakeholder Impact
- The sale of shares by a company executive could cause minor short-term fluctuations in the stock price, but the overall impact on stakeholders is likely to be minimal.
Key Dates
| Date | Description |
|---|---|
| 01/14/2025 | Date of the stock sale transaction. |
| 01/15/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.